<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Tiziana Life Sciences plc

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Tiziana Life Sciences plc

    Tiziana Life Sciences is a dual-listed (NASDAQ:TLSA, AIM:TILS) clinical stage biotechnology company that specializes in the developing transformative therapies for inflammatory diseases and cancer related to the liver. Our clinical pipeline includes drug assets for NASH, Crohn's, and hepatocellular carcinoma. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kunwar Shailubhai PhD
    • FOUNDED
      2013
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Kezar Life Sciences, Inc.

    Kezar Life Sciences, Inc.

    Based in South San Francisco, we are a clinical-stage biotechnology company commit...

    Based in South San Francisco, we are a clinical...

    Filing Type:    PU
    Genobank.io Inc

    Genobank.io Inc

    Genobank is the first privacy-preserving personal DNA Kit that guarantees consumer...

    Genobank is the first privacy-preserving person...

    Amount Raised:    $156,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Luminex Corporation

    Luminex Corporation

    LuminexÂŽ Corporation (NASDAQ: LMNX) develops, manufactures and markets proprietar...

    LuminexÂŽ Corporation (NASDAQ: LMNX) develops, ...

    Filing Type:    PU
    Axovant Gene Therapies Ltd.

    Axovant Gene Therapies Ltd.

    Axovant is accelerating the development of innovative gene therapy products that a...

    Axovant is accelerating the development of inno...

    Filing Type:    PU
    Omeros Corporation

    Omeros Corporation

    Omeros is a commercial-stage biopharmaceutical company committed to discovering, d...

    Omeros is a commercial-stage biopharmaceutical ...

    Filing Type:    PU
    Alder BioPharmaceuticals, Inc.

    Alder BioPharmaceuticals, Inc.

    Alder BioPharmaceuticals is a clinical-stage biopharmaceutical company focused on ...

    Alder BioPharmaceuticals is a clinical-stage bi...

    Filing Type:    PU
    NGM Biopharmaceuticals, Inc.

    NGM Biopharmaceuticals, Inc.

    We are a clinical stage biopharmaceutical company focused on harnessing powerful b...

    We are a clinical stage biopharmaceutical compa...

    Filing Type:    PU
    Galmed Pharmaceuticals Ltd.

    Galmed Pharmaceuticals Ltd.

    Galmed is a clinical-stage biopharmaceutical company focused on the development of...

    Galmed is a clinical-stage biopharmaceutical co...

    Filing Type:    PU
    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical compan...

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clin...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.